Avidity Partners Management LP 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 2:26 pm Sale |
2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Avidity Partners Management LP | 2,040,000 4.100% |
-2,365,000 (-53.69%) |
Filing |
| 2022-02-11 7:52 pm Purchase |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Avidity Partners Management LP | 4,405,000 9.200% |
120,000 (+2.80%) |
Filing |
| 2021-03-22 4:05 pm Purchase |
2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Avidity Partners Management LP | 4,285,000 9.400% |
4,285,000 (New Position) |
Filing |